Navigation Links
Billions spent on health IT stimulus could lead to major boom... or bust
Date:3/27/2009

Boston, Mass. The more than $19 billion dollars of funding provided for health care information technology (IT) in President Obama's economic stimulus package offers a unique opportunity to deliver on the promise of computerized health care, say researchers from Children's Hospital Boston in a Perspective article published in the March 26 issue of the New England Journal of Medicine (NEJM). The co-authors argue that the development of a platform model drawing on the success of software platforms such as the one created for the iPhone could create a flexible health information infrastructure that will improve delivery of health care, increase physician productivity, foster advances in science, as well as stimulate job and economic growth.

"This is a critical point for health IT," said co-author Kenneth Mandl, MD, PhD, of the Children's Hospital Informatics Program. "Pouring money into existing health IT systems would be the most natural approach to take with the stimulus, but it may also be the wrong approach. We need to pause and make decisions that will have long-term benefits. Rather than simply deploying existing technologies we need to establish clarity on what the characteristics of an ideal system would be."

In their NEJM article, Mandl and Isaac Kohane, MD, PhD, also of CHIP, propose for the government, through the Department of Health and Human Services (DHHS), to mandate the development of a platform that will support applications for clinical care, public health and research. Much like the software platform developed by Apple for the iPhone, or the Indivo platform created by CHIP researchers that has emerged as a model for personal health records, the co-authors encourage DHHS to mandate the creation of a platform that will support an ecosystem of applications (i.e. order entry systems, medication reconciliation systems, patient communication systems, etc.) which can be developed by existing vendors or new health IT develop
'/>"/>

Contact: Keri Stedman
keri.stedman@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. GlobalMedia Provides Free Grant Writing and Application Assistance to Healthcare Providers and Professionals Seeking Their Share of Billions in Economic Stimulus Dollars
2. Disruptive Hand Sanitation Product to Save Healthcare Industry Billions
3. Influenza Infection Costs Employers Billions Each Year; Working Adults Largest Group Not Immunized Annually
4. Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually
5. Billions for Bank Bailouts, But How to Rebuild the Brands? NeuroFocus Reveals New Brainwave-Based Solutions
6. U.S. Healthcare Efficiency Index(TM) Expands Advisory Council; Calls on Policymakers to Act on Billions in Administrative Waste
7. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
8. Insomnia Costs Billions in Lost Productivity
9. Proposed Truck Clean-Up Rule Will Save Billions in Health-Related Costs for Truckers and Other Californians
10. American Association for Homecare Proposes Aggressive 13-Point Plan to Stop Medicare Fraud and Recoup Billions; Calls Steps Essential to Medicares Health
11. Mental Illness Costs U.S. Billions in Lost Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 1U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 4U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 5West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 1Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 2